Metabolic Control of Type 2 Diabetes by Targeting the GLUT4 Glucose Transporter: Intervention Approaches

E-ISSN： 1873-4286|22|20|3034-3049

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.20, 2016-06, pp. : 3034-3049

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes

By Boyle Luke D Wilding John PH

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 375-391

Informa Healthcare

Access to resources Recommend Favorite

Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes

By Lamos Elizabeth M Younk Lisa M Davis Stephen N

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 875-882

Informa Healthcare

Access to resources Recommend Favorite

Higher Serum Retinol Binding Protein 4 May be a Predictor of Weak Metabolic Control in Chinese Patients with Type 2 Diabetes Mellitus

By Wang MN Han YB Li Q Guo L Yang YM Wang W Zhang JC

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1317-1324

Field House Publishing

Access to resources Recommend Favorite

Metformin interaction with insulin-regulated glucose uptake, using the Xenopus laevis oocyte model expressing the mammalian transporter GLUT4

By Detaille D. Wiernsperger N. Devos P.

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 127-136

Elsevier

Access to resources Recommend Favorite

Searching for Ways to Upregulate GLUT4 Glucose Transporter Expression in Muscle - Investigation of biochemical characteristics and translocation

By Zorzano A. Santalucia T. Palacn M. Guma A. Camps M.

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 705-713

Elsevier

Access to resources Recommend Favorite